These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26296199)

  • 1. Parkinson's disease psychosis: symptoms, management, and economic burden.
    Hermanowicz N; Edwards K
    Am J Manag Care; 2015 Aug; 21(10 Suppl):s199-206. PubMed ID: 26296199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden.
    Fredericks D; Norton JC; Atchison C; Schoenhaus R; Pill MW
    Am J Manag Care; 2017 Apr; 23(5 Suppl):S83-S92. PubMed ID: 28715903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis in Parkinson's Disease: Current Treatment Options and Impact on Patients and Caregivers.
    Segal GS; Xie SJ; Paracha SU; Grossberg GT
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):274-279. PubMed ID: 34219522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries.
    Rajagopalan K; Rashid N; Gopal D; Doshi D
    Int J Geriatr Psychiatry; 2023 Nov; 38(11):e6017. PubMed ID: 37936540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis in Parkinson's Disease: A Lesson from Genetics.
    Angelopoulou E; Bougea A; Papageorgiou SG; Villa C
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel.
    Pahwa R; Isaacson SH; Small GW; Torres-Yaghi Y; Pagan F; Sabbagh M
    Neurol Ther; 2022 Dec; 11(4):1571-1582. PubMed ID: 35906500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in institutionalization, healthcare resource utilization, and mortality risk associated with Parkinson disease psychosis: Retrospective cohort study.
    Wetmore JB; Li S; Yan H; Irfan M; Rashid N; Peng Y; Gilbertson DT; Shim A
    Parkinsonism Relat Disord; 2019 Nov; 68():95-101. PubMed ID: 31679990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of onset of psychosis in patients with Parkinson's disease: Who gets it early?
    Lenka A; George L; Arumugham SS; Hegde S; Reddy V; Kamble N; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2017 Nov; 44():91-94. PubMed ID: 28928050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Pimavanserin and Maintenance Electroconvulsive Therapy: A Novel Approach to Parkinson's Disease Psychosis.
    Imlay RK; Alsayed M; Starcher M; Tager A; Griffith J
    Cureus; 2024 Jul; 16(7):e64316. PubMed ID: 39130906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice.
    Dashtipour K; Gupta F; Hauser RA; Karunapuzha CA; Morgan JC
    Parkinsons Dis; 2021; 2021():2603641. PubMed ID: 33489083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of psychosis in Parkinson's disease.
    D'Souza C; Gupta A; Alldrick MD; Sastry BS
    Int J Clin Pract; 2003 May; 57(4):295-300. PubMed ID: 12800461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010).
    Stang CD; Mullan AF; Camerucci E; Hajeb M; Turcano P; Martin P; Mielke MM; Josephs KA; Splett M; Abler V; Boeve BF; Bower JH; Savica R
    J Parkinsons Dis; 2022; 12(4):1319-1327. PubMed ID: 35213389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability.
    Schrag A; Hovris A; Morley D; Quinn N; Jahanshahi M
    Parkinsonism Relat Disord; 2006 Jan; 12(1):35-41. PubMed ID: 16271496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease.
    Martinez-Martin P; Rodriguez-Blazquez C; Forjaz MJ; Frades-Payo B; Agüera-Ortiz L; Weintraub D; Riesco A; Kurtis MM; Chaudhuri KR
    Parkinsonism Relat Disord; 2015 Jun; 21(6):629-34. PubMed ID: 25892660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
    Forns J; Layton JB; Bartsch J; Turner ME; Dempsey C; Anthony M; Ritchey ME; Demos G
    PLoS One; 2021; 16(1):e0246121. PubMed ID: 33503061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosis in nursing home patients with Parkinson's disease.
    Kang GA; Bronstein JM
    J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of psychosis in Parkinson's disease.
    Fénelon G; Alves G
    J Neurol Sci; 2010 Feb; 289(1-2):12-7. PubMed ID: 19740486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-year population-based study of psychosis in Parkinson disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Goetz CG; Stebbins GT; Aarsland D; Alves G
    Arch Neurol; 2010 Aug; 67(8):996-1001. PubMed ID: 20697051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor and non-motor symptoms in Turkish patients with Parkinson's disease affecting family caregiver burden and quality of life.
    Ozdilek B; Gunal DI
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):478-83. PubMed ID: 23224455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.